“Strategic Stock Sales by Top General Counsels Highlight Executive Financial Strategies Amid Market Uncertainty”
In September, notable stock transactions by general counsels captured attention, particularly within major corporations such as United Therapeutics and Apple. Chief among these was United Therapeutics’ general counsel, Paul Mahon, who executed a significant stock sale amounting to $8.1 million. This transaction highlights the financial strategies some top executives are employing amidst fluctuating market conditions….